Search clinical trials for: LHRH agonist (antagonist) therapy
Total 5710 results
-
University of AarhusUnknown
-
Eli Lilly and CompanyBayerActive, not recruitingProstatic NeoplasmsSpain, Germany, United States
-
Rabin Medical CenterFerring PharmaceuticalsCompletedCardiovascular Diseases | Prostatic NeoplasmsIsrael
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedProstate CancerUnited States, Canada
-
Sidney Kimmel Cancer Center at Thomas Jefferson...SanofiCompleted
-
University Hospital "Sestre Milosrdnice"UnknownProstate CancerCroatia
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Tianjin Medical University Cancer Institute and...Peking University First Hospital; The Affiliated Nanjing Drum Tower Hospital... and other collaboratorsUnknownStage III Prostate CancerChina
-
Hoffmann-La RocheRecruitingEarly Breast CancerUnited States, Spain, France, Korea, Republic of, China, Italy, Taiwan, Sweden, Czechia, Hungary, Japan, Greece, Hong Kong, Ukraine, Australia, Brazil, Canada, Mexico, Belgium, Kenya, Argentina, Chile, Serbia, South Africa, Colombia, Ireland and more
-
University Health Network, TorontoCompleted
-
Ferring PharmaceuticalsCompleted
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyActive, not recruitingProstate CancerUnited States, Canada
-
Ajjai Alva, MDHoosier Cancer Research Network; Bayer Healthcare Pharmaceuticals, Inc./Bayer...TerminatedProstate Cancer | Bone Metastases | Prostate NeoplasmsUnited States
-
University of LahoreCompleted
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedProstate CancerUnited States, Canada
-
Lawson Health Research InstituteCompleted
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyActive, not recruitingProstate CancerUnited States, Canada
-
Centre of Experimental MedicineMillennium Pharmaceuticals, Inc.TerminatedProstate CancerUnited Kingdom
-
Lawson Health Research InstituteTerminated
-
The Methodist Hospital Research InstituteCelgene CorporationTerminatedProstatic NeoplasmsUnited States
-
Tianjin Medical University Cancer Institute and...Peking University First Hospital; The Affiliated Nanjing Drum Tower Hospital... and other collaboratorsUnknownStage IV Prostate CancerChina
-
European Organisation for Research and Treatment...Withdrawn
-
European HospitalUnknownEmbryo's Genetic and Chromosomal QualityItaly
-
European Organisation for Research and Treatment...Completed
-
Genentech, Inc.TerminatedBreast CancerUnited States, Korea, Republic of, Spain, Netherlands
-
Juravinski Cancer CenterSanofiUnknown
-
Wirral University Teaching Hospital NHS TrustCompleted
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompleted
-
Peter MacCallum Cancer Centre, AustraliaUnknownProstate CancerAustralia, New Zealand
-
Genentech, Inc.Active, not recruitingBreast CancerUnited States, Spain, Korea, Republic of, Australia, United Kingdom
-
Hoffmann-La RocheRecruitingEstrogen Receptor-Positive, HER2-Negative Advanced Breast CancerBelgium, Korea, Republic of, United States, Canada, China, Italy, France, Brazil, Australia, Argentina, Portugal, Spain, Taiwan, Costa Rica, New Zealand, Poland, Chile, Colombia, Guatemala, Israel, Hungary, India, Thailand
-
Merck KGaA, Darmstadt, GermanyCompleted
-
Dana-Farber Cancer InstituteJanssen Scientific Affairs, LLCActive, not recruiting
-
Umeå UniversityKarolinska University Hospital; Vastra Gotaland Region; Region Jönköping County; Region Skane and other collaboratorsRecruitingProstate Cancer Metastatic | Positron-Emission Tomography | Radiation TherapySweden
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast CancerUnited States, Italy, Korea, Republic of, Canada, Germany, United Kingdom, Australia, Belgium, Brazil, China, Denmark, France, Hong Kong, Portugal, Spain, Taiwan, Turkey, Japan, Argentina, Mexico, Israel, Poland, Russian Federation, Peru and more
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG Oncology; Cancer and Leukemia Group BActive, not recruitingProstate CancerUnited States, Canada, China, Israel
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerUnited States, Korea, Republic of, China, Poland, Taiwan, Turkey, United Kingdom, Australia, Argentina, Germany, Singapore, Thailand, Israel, Russian Federation, Ukraine, Brazil, South Africa
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NCIC Clinical Trials GroupCompleted
-
Dana-Farber Cancer InstituteEli Lilly and CompanyRecruitingBreast Cancer | Early-stage Breast Cancer | High Risk Breast CarcinomaUnited States
-
Region Örebro CountyUppsala-Örebro Regional Research CouncilCompletedPuberty, PrecociousSweden
-
Boehringer IngelheimHealthCore-NERICompleted
-
Massachusetts General HospitalNational Institutes of Health (NIH)Unknown
-
Dana-Farber Cancer InstituteBayer; Decipher BiosciencesRecruiting
-
Universität des SaarlandesCompleted
-
AstraZenecaActive, not recruitingER-Positive HER2-Negative Breast CancerAustria, Belgium, France, Germany, Italy, United Kingdom, United States, Canada, India, Taiwan, Russian Federation, Korea, Republic of, Hungary, Japan, Mexico, Turkey, China, Malaysia, Spain, Czechia, Portugal, Poland, Norway, Bulgaria, Slovaki... and more
-
AstraZenecaRecruitingER-Positive HER2-Negative Breast CancerUnited States, Israel, Spain, Korea, Republic of, Italy, Poland, Belgium, Norway, Bulgaria, France, Germany, United Kingdom, Japan, Taiwan, Canada, Hungary, Australia, Austria, Portugal, Turkey, Russian Federation, Slovakia, Switzer...
-
Massachusetts General HospitalNational Institute on Aging (NIA)Unknown
-
University of Southern CaliforniaNational Cancer Institute (NCI); AEterna ZentarisCompletedRecurrent Prostate Cancer | Prostate Cancer | Hormone-resistant Prostate Cancer | Stage IV Prostate CancerUnited States
-
ActelionWithdrawn